Liver transplant for hard-to-treat bile duct cancer
Part of Cancer clinical trials.
This trial studies liver transplantation to treat a specific bile duct cancer (perihilar cholangiocarcinoma) that cannot be removed by surgery. It aims to see if a transplant can help when standard chemotherapy has kept the cancer stable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a type of bile duct cancer (perihilar cholangiocarcinoma) confirmed by biopsy or imaging.
- Your tumor is in a part of the bile ducts that can't be removed with standard surgery.
- You have not had other cancer spread to your lymph nodes or other organs.
- The tumor is 3 cm or smaller in width.
- You have had at least 6 months of standard chemotherapy and your cancer has not grown or has shrunk.
- You are generally healthy enough for a liver transplant and do not have active infections or other major medical problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a liver transplant can help people with a specific type of bile duct cancer (perihilar) that cannot be removed with surgery. It aims to offer a potential cure for those whose tumor is small and hasn't spread.
This study tests whether robot-assisted surgery is safe and effective for people with perihilar cholangiocarcinoma (a type of bile duct cancer). It may be a good fit for patients whose cancer has not spread and who are healthy enough for major surgery.
This trial studies liver transplantation for people with a specific type of bile duct cancer near the liver that cannot be safely removed by surgery. It aims to improve outcomes by offering a transplant after the cancer responds to chemotherapy and spread has been ruled out on scans.
This trial tests whether giving chemotherapy (gemcitabine and cisplatin) combined with immunotherapy (pembrolizumab) before and after surgery can improve outcomes compared to having surgery right away. It is for people with bile duct cancer that can be removed or is borderline removable.
This trial tests if a liver transplant can help people with a certain type of bile duct cancer (intrahepatic cholangiocarcinoma) that cannot be surgically removed. You must have had at least six months of chemotherapy and your cancer must be stable or smaller before you can be listed for a transplant.
This study tests if a liver transplant can help people with a type of bile duct cancer (intrahepatic cholangiocarcinoma) that cannot be surgically removed. It is for patients whose cancer has been stable for at least 6 months after initial treatments.
Hear when a new Perihilar Cholangiocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.